CRA experts advised counsel and presented before the FTC on transactions involving Novartis’ acquisition of cancer drugs from GlaxoSmithKline, GSK’s joint venture with Novartis on consumer health, and Novartis’s sale of Novartis Animal Health to Eli Lilly & Co. The deals ultimately went forward with certain divestitures.
2023 Annual Review of Antitrust Law Developments
CRA’s Yajing Jiang contributed to Chapter 1 “Restraints of Trade” of the 2023 Annual Review of Antitrust Law Developments recently published by the ABA...